title: NASPGHAN Clinical Practice Guideline for the Diagnosis and Treatment of Nonalcoholic Fatty Liver Disease in Children: Recommendations from the Expert Committee on NAFLD (ECON) and the North American Society of Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN).
abstract: Nonalcoholic fatty liver disease (NAFLD) is a highly prevalent chronic liver disease that occurs in the setting of insulin resistance and increased adiposity. It has rapidly evolved into the most common liver disease seen in the pediatric population and is a management challenge for general pediatric practitioners, subspecialists, and for health systems. In this guideline, the expert committee on NAFLD reviewed and summarized the available literature, formulating recommendations to guide screening and clinical care of children with NAFLD.
authors.affiliation: *School of Medicine, Emory University †Children's Healthcare of Atlanta, Atlanta, GA ‡Texas Children's Hospital §Baylor College of Medicine, Houston, TX ||School of Medicine, Yale University, New Haven, CT ¶School of Medicine, University of Colorado, Denver #Children's Hospital Colorado, Aurora, CO **Cincinnati Children's Hospital Medical Center ††Department of Pediatrics, University of Cincinnati, Cincinnati, OH ‡‡Hospital for Sick Children §§School of Medicine, University of Toronto, Toronto ||||Janeway Children's Health and Rehabilitation Centre ¶¶Discipline of Pediatrics, Faculty of Medicine, Memorial University of Newfoundland, St. John's, NL, Canada ##School of Medicine, University of California San Diego ***Rady Children's Hospital, San Diego, CA.
authors.forename: Miriam B
authors.initials: MB
authors.lastname: Vos
authors.forename: Stephanie H
authors.initials: SH
authors.lastname: Abrams
authors.forename: Sarah E
authors.initials: SE
authors.lastname: Barlow
authors.forename: Sonia
authors.initials: S
authors.lastname: Caprio
authors.forename: Stephen R
authors.initials: SR
authors.lastname: Daniels
authors.forename: Rohit
authors.initials: R
authors.lastname: Kohli
authors.forename: Marialena
authors.initials: M
authors.lastname: Mouzaki
authors.forename: Pushpa
authors.initials: P
authors.lastname: Sathya
authors.forename: Jeffrey B
authors.initials: JB
authors.lastname: Schwimmer
authors.forename: Shikha S
authors.initials: SS
authors.lastname: Sundaram
authors.forename: Stavra A
authors.initials: SA
authors.lastname: Xanthakos
mesh_terms: D050110:Bariatric Surgery; D002648:Child; D003131:Combined Modality Therapy; D004035:Diet Therapy; D005081:Exercise Therapy; D005765:Gastrointestinal Agents / Q000627:therapeutic use; D006801:Humans; D015994:Incidence; D065626:Non-alcoholic Fatty Liver Disease / Q000175:diagnosis* / Q000453:epidemiology / Q000209:etiology / Q000628:therapy*; D015995:Prevalence; D012307:Risk Factors; D012720:Severity of Illness Index; D014481:United States / Q000453:epidemiology
chemical_list: D005765:Gastrointestinal Agents